Pop, Roxana; Kaelin, Marisa B; Kuster, Stefan P; Sax, Hugo; Rampini, Silvana K; Zbinden, Reinhard; Relly, Christa; Zacek, Bea; Bassler, Dirk; Fontijn, Jehudith R; Berger, Christoph (2022). Low secondary attack rate after prolonged exposure to sputum smear positive miliary tuberculosis in a neonatal unit. Antimicrobial resistance and infection control, 11(1), p. 148. BioMed Central 10.1186/s13756-022-01179-8
|
Text
s13756-022-01179-8.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
BACKGROUND
Several neonatal intensive care units (NICU) have reported exposure to sputum smear positive tuberculosis (TB). NICE guidelines give support regarding investigation and treatment intervention, but not for contact definitions. Data regarding the reliability of any interferon gamma release assay (IGRA) in infants as a screening test for TB infection is scarce. We report an investigation and management strategy and evaluated the viability of IGRA (T-Spot) in infants and its concordance to the tuberculin skin test (TST).
METHODS
We performed an outbreak investigation of incident TB infection in a NICU after prolonged exposure to sputum smear positive miliary TB by an infant's mother. We defined individual contact definitions and interventions and assessed secondary attack rates. In addition, we evaluated the technical performance of T-Spot in infants and compared the results with the TST at baseline investigation.
RESULTS
Overall, 72 of 90 (80%) exposed infants were investigated at baseline, in 51 (56.7%) of 54 (60%) infants, follow-up TST at the age of 6 months was performed. No infant in our cohort showed a positive TST or T-Spot at baseline. All blood samples from infants except one responded to phytohemagglutinin (PHA), which was used as a positive control of the T-Spot, demonstrating that cells are viable and react upon stimulation. 149 of 160 (93.1%) exposed health care workers (HCW) were investigated. 1 HCW was tested positive, having no other reason than this exposure for latent TB infection. 5 of 92 (5.5%) exposed primary contacts were tested positive, all coming from countries with high TB incidences. In total, 1 of 342 exposed contacts was newly diagnosed with latent TB infection. The secondary attack rate in this study including pediatric and adult contacts was 0.29%.
CONCLUSION
This investigation highlighted the low transmission rate of sputum smear positive miliary TB in a particularly highly susceptible population as infants. Our expert definitions and interventions proved to be helpful in terms of the feasibility of a thorough outbreak investigation. Furthermore, we demonstrated concordance of T-Spot and TST. Based on our findings, we assume that T-Spot could be considered a reliable investigation tool to rule out TB infection in infants.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Sax, Hugo Siegfried |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2047-2994 |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
07 Dec 2022 10:50 |
Last Modified: |
07 Dec 2022 18:38 |
Publisher DOI: |
10.1186/s13756-022-01179-8 |
PubMed ID: |
36471416 |
Uncontrolled Keywords: |
Infant, outbreak investigation Interferon gamma release assay Neonatal intensive care unit Neonate Quantiferon T-Spot TST Tuberculosis |
BORIS DOI: |
10.48350/175527 |
URI: |
https://boris.unibe.ch/id/eprint/175527 |